Abstract
The development and application of high throughput in vitro assays is an important development for risk assessment in the twenty-first century. However, there are still significant challenges to incorporate in vitro assays into routine toxicity testing practices. In this paper, a robust learning approach was developed to infer the in vivo point of departure (POD) with in vitro assay data from ToxCast and Tox21 projects. Assay data from ToxCast and Tox21 projects were utilized to derive the in vitro PODs for several hundred chemicals. These were combined with in vivo PODs from ToxRefDB regarding the rat and mouse liver to build a high-dimensional robust regression model. This approach separates the chemicals into a majority, well-predicted set; and a minority, outlier set. Salient relationships can then be learned from the data. For both mouse and rat liver PODs, over 93% of chemicals have inferred values from in vitro PODs that are within ± 1 of the in vivo PODs on the log10 scale (the target learning region, or TLR) and R2 of 0.80 (rats) and 0.78 (mice) for these chemicals. This is comparable with extrapolation between related species (mouse and rat), which has 93% chemicals within the TLR and the R2 being 0.78. Chemicals in the outlier set tend to also have more biologically variable characteristics. With the continued accumulation of high throughput data for a wide range of chemicals, predictive modeling can provide a valuable complement for adverse outcome pathway based approach in risk assessment.
Similar content being viewed by others
Abbreviations
- AOP:
-
Adverse outcome pathway
- BMAD:
-
Baseline median absolute deviation
- BMD:
-
Benchmark dose
- BMDL:
-
The statistical lower bound of BMD
- EPA:
-
Environmental Protection Agency
- EU:
-
European Union
- FDA:
-
Food and Drug Administration
- LASSO:
-
Least absolute shrinkage and selection operator
- LEL:
-
Lowest effect level
- LOAEL:
-
Lowest observed adverse effect level
- NCATS:
-
National Center for Advancing Translational Sciences
- NIH:
-
National Institute of Health
- NOAEL:
-
No observed adverse effect level
- NTP:
-
National Toxicology Program
- POD:
-
Point of departure
- REACH:
-
Registration, evaluation, authorization and restriction of chemical substances
- TG-GATEs:
-
Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System
- TLR:
-
Target learning region
References
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD et al (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–741
Collins FS, Gray GM, Bucher JR (2008) Transforming environmental health protection. Science 319:906–907
Farmahin R, Williams A, Kuo B, Chepelev NL, Thomas RS, Barton-Maclaren TS, Curran IH, Nong A, Wade MG, Yauk CL (2017) Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment. Arch Toxicol 91:2045–2065
Filer DL, Kothiya P, Setzer RW, Judson RS, Martin MT (2016) tcpl: the ToxCast pipeline for high-throughput screening data. Bioinformatics 33:618–620
Hastie T, Tibshirani R, Friedman J (2009) The element of statistical learning, 2nd edn. Springer, New York
Huang R, Xia M, Sakamuru S, Zhao J, Shahane SA, Attene-Ramos M, Zhao T, Austin CP, Simeonov A (2016) Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization. Nat Commun 7:10425. https://doi.org/10.1038/ncomms10425
Igarashi Y, Nakatsu N, Yamashita T, Ono A, Ohno Y, Urushidani T, Yamada H (2015) Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res 43:D921–D927
Judson R, Houck K, Martin M, Knudsen T, Thomas R, Sipes N, Shah I, Wambaugh J, Crofton ANDK (2014) In Vitro and Modeling Approaches to Risk Assessment from the US Environmental Protection Agency ToxCast Program. Basic Clin Pharmacol Toxicol 115:69–76
Kavlock R, Dix D (2010) Computational toxicology as implemented by the US EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard, and risk. J Toxicol Environ Health B Crit Rev 13:197–217
Kleinstreuer N, Ceger P, Watt E, Martin M, Houck K, Browne P, Thomas R, Casey W, Dix D, Allen D, Sakamuru S, Xia M, Huang R, Judson R (2017) Development and validation of a computational model for androgen receptor activity. Chem Res Toxicol 30:946–964
Knapen D, Vergauwen L, Villeneuve DL, Ankley GT (2015) The potential of AOP networks for reproductive and developmental toxicity assay development. Reprod Toxicol 56:52–55
Kodell RL (2009) Replace the NOAEL and LOAEL with the BMDL01 and BMDL10. Environ Ecol Stat 16:3–12
Liu J, Mansouri K, Judson RS, Martin MT, Hong H, Chen M, Xu X, Thomas RS, Shah I (2015) Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure. Chem Res Toxicol 28:738–751
Locke PA, Westphal M, Tischler J, Hessler K, Frasch P, Myers B, Krewski D (2017) Implementing toxicity testing in the 21st century: challenges and opportunities. Int J Risk Assess Manag 20:198–225
Maronna RA (2011) Robust ridge regression for high-dimensional data. Technometrics 53:44–53
Maronna RA, Martin DR, Yohai VJ (2006) Robust statistics: theory and methods, 1st edn. Wiley, New York
Martin MT, Judson RS, Reif DM, Kavlock RJ, Dix DJ (2009) Profiling chemicals based on chronic toxicity results from the US EPA ToxRef Database. Environ Health Perspect 117:1–8
Martin MT, Knudsen TB, Reif DM, Houck KA, Judson RS, Kavlock RJ, Dix DJ (2011) Predictive model of rat reproductive toxicity from ToxCast high throughput screening. Biol Reprod 85:327–339
NRC (National Research Council) (2007) Toxicity testing in the 21st century: a vision and a strategy. The National Academies Press, Washington, DC
NRC (National Research Council) (2017) Using 21st century science to improve risk-related evaluations. The National Academies Press, Washington, DC
Pham N, Iyer S, Hackett E, Lock BH, Sandy M, Zeise L, Solomon G, Marty M (2016) Using ToxCast to explore chemical activities and hazard traits: a case study with orthophthalates. Toxicol Sci 151:286–301
Richard A, Judson R, Houck K, Grulke C, Volarath P, Thillainadarajah I et al (2016) The ToxCast chemical landscape—paving the road to 21st century toxicology. Chem Res Toxicol 29:1225–1251
Rudén C, Hansson SO (2010) Registration, evaluation, and authorization of chemicals (REACH) is but the first step. How far will it take us? Six further steps to improve the European chemicals legislation. Environ Health Perspect 118:6–10
Shah I, Setzer RW, Jack J, Houck KA, Judson RS, Knudsen TB et al (2016) Using ToxCast™ data to reconstruct dynamic cell state trajectories and estimate toxicological points of departure. Environ Health Perspect 124:910–919
Silva M, Pham N, Lewis C, Iyer S, Kwok E, Solomon G, Zeise L (2015) A comparison of ToxCast test results with in vivo and other in vitro endpoints for neuro, endocrine, and developmental toxicities: a case study using endosulfan and methidathion. Birth Defects Res B Dev Reprod Toxicol 104:71–89
Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I et al (2016) Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect 124:713–721
Smucler E, Yohai VJ (2017) Robust and sparse estimators for linear regression models. Comput Stat Data Anal 111:116–130
Tice RR, Austin CP, Kavlock RJ, Bucher JR (2013) Improving the human hazard characterization of chemicals: a Tox21 Update. Environ Health Perspect 121:756–765
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA et al (2014) Adverse outcome pathway development II: best practices. Toxicol Sci 142:321–330
Yang L, Allen BC, Thomas RS (2007) BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genom 8:387
Acknowledgements
The author wishes to thank Drs. Weida Tong, Zhichao Liu, Huixiao Hong, Qiang Shi, and Mei Nan at National Center for Toxicological Research for valuable discussion and comments. The author also wants to thank an anonymous referee for valuable comments. The opinions expressed in this paper are those of the author and do not necessarily reflect the views of the US Food and Drug Administration.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, D. Infer the in vivo point of departure with ToxCast in vitro assay data using a robust learning approach. Arch Toxicol 92, 2913–2922 (2018). https://doi.org/10.1007/s00204-018-2260-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-018-2260-6